Page 5 - Pharma Plc News Today

N4 Pharma Plc (LON:N4P – Free Report) shares hit a new 52-week low during trading on Friday . The stock traded as low as GBX 1.50 ($0.02) and last traded at GBX 1.64 ($0.02), with a volume of 214540 shares. The stock had previously closed at GBX 1.60 ($0.02). N4 Pharma Stock Performance The company […]

N4 Pharma Plc (LON:N4P – Free Report)’s share price reached a new 52-week low on Friday . The stock traded as low as GBX 1.50 ($0.02) and last traded at GBX 1.64 ($0.02), with a volume of 214540 shares. The stock had previously closed at GBX 1.60 ($0.02). N4 Pharma Price Performance The firm has […]

Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a p...

In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a price...

Redx Pharma Plc (LON:REDX – Get Rating)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 25.03 ($0.32) and last traded at GBX 27.88 ($0.36), with a volume of 110 shares traded. The stock had previously closed at GBX 26.50 ($0.34). Redx Pharma Stock […]

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $3...

In this article, we will take a look at the 10 stocks that are seeing significant buy-side insider activity.

Poolbeg Pharma PLC Announces Board Appointment

On May 12 Katie Stockton, founder and managing partner of Fairlead Strategies, appeared in an interview on CNBC to discuss current market trends and her outlook for the back half of 2023.